A comparison of treatment patterns, healthcare resource utilization, and costs among young adult Medicaid beneficiaries with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics in the US

10.2146/ajhp140219

10.1016/j.jval.2014.08.293

10.1016/S0924-9338(14)70001-X

10.4088/JCP.15m10278

Chong HY, 2016, Neuropsychiatr Dis Treatment, 12

10.1080/13696998.2018.1500370

Kreyenbuhl J, 2010, Bull, 36, 94

10.1080/03007995.2016.1219706

10.18553/jmcp.2015.21.9.754

10.18553/jmcp.2016.22.11.1349

10.9758/cpn.2012.10.2.78

10.1001/jamapsychiatry.2015.0270

Invega Sustenna, 2015, (paliperidone palmitate) extended-release injectable suspension US prescribing information [Internet]

Pilon D, 2017, BMC Psychiatry, 17

10.4088/JCP.16m10745

10.1016/0895-4356(92)90133-8

Centers for Medicare & Medicaid Services [Internet]. (2017, November 24). Medicaid Drug Rebate Program; 2017. Available at: https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html [Last accessed 22 May 2018]

Prices for brand-name drugs under selected Federal programs. Washington, DC: Congressional Budget Office; 2005. Available at: https://www.cbo.gov/sites/default/files/109th-congress-2005-2006/reports/06-16-prescriptdrug.pdf [Last accessed 9 May 2018]

10.1080/00273171.2011.568786

10.1080/03610910902859574

10.1177/2045125312474019

Fitch K, 2014, Am Health Drug Benefits, 7, 18

10.3111/13696998.2012.751025

Xiao Y, 2015, J Comp Eff Res, 14, 1

10.1176/appi.ps.201400042

10.1186/s12888-017-1507-8

Medicaid Benefits: Prescription Drugs. Henry J Kaiser Family Foundation; 2012. Available at: https://www.kff.org/medicaid/state-indicator/prescription-drugs/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D [Last accessed 7 August 2018]